This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Federman & Sherwood Investigates GenOn Energy, Inc. For Possible Breaches Of Fiduciary Duty

The law firm of Federman & Sherwood has initiated an investigation into Houston-based GenOn Energy, Inc. (NYSE:GEN) (“GenOn”) with respect to possible breaches of fiduciary duty by the company’s officers and directors, as well as violations of state law, in connection with the take-over bid offer by NRG Energy, Inc. (“NRG”).

On July 23, 2012, GenOn announced that it had agreed to be acquired by NRG, whereby NRG would acquire all outstanding shares of GenOn common stock in a cash offer of approximately $1.7 billion. Based upon the terms of the proposal, GenOn shareholders would receive 0.1216 shares of NRG stock for each share of GenOn they own at the time the transaction is finalized. Hypothetically, based upon the closing price of $18.05 for NRG shares as of July 20, 2012, this would result in each GenOn shareholder receiving $2.19 for each share of GenOn they own at the time of the buyout.

Federman & Sherwood is investigating whether: (1) the information being provided to GenOn shareholders makes all necessary disclosures with respect to the proposed sales transaction; (2) whether the proposed sale to NRG offers adequate long-term value to GenOn shareholders; and, (3) whether GenOn could have received a higher per share price for its shareholders had the officers and directors aggressively sought other purchasers for the company. At least one analyst has set a target price of $4.50 for GenOn common stock.

If you currently own common stock in GenOn Energy, Inc. and purchased your shares before July 23, 2012; have information to assist in our investigation of this transaction; or, have any questions or concerns regarding this notice or preservation of your rights, please contact William B. Federman. Federman & Sherwood has extensive nationwide experience in representing investors in securities, derivative and merger-related shareholder class actions, and has been appointed as lead counsel in multiple complex cases.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,751.39 +121.12 0.69%
S&P 500 2,108.57 +15.32 0.73%
NASDAQ 5,111.7330 +22.5270 0.44%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs